ALVOW vs. ATNFW, LBPSW, AEHAW, AIMDW, ACABW, ACABU, BFRIW, BTMDW, BCTXW, and CELUW
Should you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.
180 Life Sciences (NASDAQ:ATNFW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership, risk, community ranking and media sentiment.
In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.
180 Life Sciences and Alvotech both received 0 outperform votes by MarketBeat users.
Summary
Alvotech beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.
Get Alvotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALVOW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ALVOW vs. The Competition
Alvotech Competitors List
Related Companies and Tools
Free ALVOW Stock Alerts